Asthma, beta-agonists, and development of congestive heart failure: results of the ABCHF study

J Card Fail. 2002 Aug;8(4):232-8. doi: 10.1054/jcaf.2002.127771.

Abstract

Background: Previous studies demonstrated an association between asthma and idiopathic dilated cardiomyopathy (IDCM), raising concerns regarding chronic beta-agonist inhaler use. The purpose of this investigation was to replicate that association.

Methods and results: We identified 67 patients with IDCM and 130 controls with predominately ischemic cardiomyopathy. Patients were administered a structured, detailed phone survey by blinded interviewers, and had chart abstractions performed. We had 80% power to detect an odds ratio (OR) > or = 2.6 for the relation of asthma and IDCM. A history of asthma was present in 19.4% v 12.3% for cases and controls respectively, OR, 1.72, (95% confidence interval [CI], 0.72, 4.09), P = .18. The duration of asthma was higher in cases: 32.3 (19.7) years v 13.8 (15.0) years (P = 0.007). With adjustment for confounders, multivariate analyses revealed no significant relations between asthma or beta-agonist use and the later development of IDCM.

Conclusions: It is unlikely that previously occurring asthma or beta-agonist use has a strong relationship to the development of IDCM; however, IDCM and atopic diseases may cluster in families, warranting further work into the genetic relations between atopy and IDCM.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use*
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiac Catheterization
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / etiology
  • Dyspnea, Paroxysmal / drug therapy*
  • Dyspnea, Paroxysmal / epidemiology
  • Dyspnea, Paroxysmal / etiology*
  • Echocardiography
  • Family Health
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / epidemiology
  • Heart Failure / etiology*
  • Humans
  • Interviews as Topic
  • Male
  • Michigan
  • Middle Aged
  • Multivariate Analysis
  • Pulmonary Wedge Pressure / physiology
  • Risk Factors
  • Severity of Illness Index
  • Stroke Volume / physiology
  • Treatment Outcome

Substances

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors